Autoantibodies in Neurodegenerative Diseases: Antigen-specific Frequencies and Intrathecal Analysis
Overview
Neurology
Physiology
Authors
Affiliations
The frequency of autoantibodies (AAbs) was surveyed in several neurodegenerative diseases, other neurological diseases, and controls using antigen-specific EIAs for neurofilament heavy subunit, tubulin, glial fibrillary acidic protein, S100 protein, tau, beta-amyloid peptide, myelin basic protein, and heparan sulfate proteoglycan. High frequencies of sera and cerebrospinal fluid tubulin AAbs were found in Alzheimer disease (62% and 69%, respectively), Parkinson disease (27% and 70%), amyotrophic lateral sclerosis (54% and 67%), and in sera from multiple sclerosis (50% and 67%), optic neuritis (85%), Guillain-Barré syndrome (88%), and vascular dementia (52%). High frequencies of neurofilament heavy subunit AAbs were detected in Guillain-Barré syndrome, chronic peripheral neuropathy (88%) and optic neuritis (62%); whereas, some Alzheimer's disease (33%) and vascular dementia (44%) patients had glial fibrillary acidic protein AAbs. Lower frequencies of other AAbs were found in patient groups. AAb results were also compared to functional assessment of blood-brain barrier integrity in Parkinson's disease and Alzheimer's disease. The relevance of these AAbs to pathogenesis and/or course of neurologic diseases merits further study with particular reference to subgrouping and prognosis.
Ehtewish H, Mesleh A, Ponirakis G, Lennard K, Hamad H, Chandran M Front Neurol. 2023; 14:1256745.
PMID: 38107644 PMC: 10722091. DOI: 10.3389/fneur.2023.1256745.
Pandey M Front Aging Neurosci. 2022; 14:902191.
PMID: 35721016 PMC: 9204601. DOI: 10.3389/fnagi.2022.902191.
Autoantibodies targeting neuronal proteins as biomarkers for neurodegenerative diseases.
Kocurova G, Ricny J, Ovsepian S Theranostics. 2022; 12(7):3045-3056.
PMID: 35547759 PMC: 9065204. DOI: 10.7150/thno.72126.
Biomarker of Neuroinflammation in Parkinson's Disease.
Liu T, Chen C, Chang K Int J Mol Sci. 2022; 23(8).
PMID: 35456966 PMC: 9028544. DOI: 10.3390/ijms23084148.
Serum and Saliva Myelin Basic Protein as Multiple Sclerosis Biomarker.
Mirzaii-Dizgah M, Mirzaii-Dizgah M, Mirzaii-Dizgah I Basic Clin Neurosci. 2021; 12(3):309-314.
PMID: 34917290 PMC: 8666920. DOI: 10.32598/bcn.2021.950.2.